AstraZeneca’s pain is resulting in a big gain for Pfizer and BioNTech in the global vaccine war, according to a report by online investment website, Motley Fool. And those gains could be further enhanced, following reports that Pfizer and BioNTech will boost their vaccine prices by more than 60% going forward, resulting in massive profits […]
Thank you for registering!
An account was already registered with this email. Please check your inbox for an authentication link.